Limited antibody response after BA.4/5 adapted booster vaccination in
rheumatic patients receiving anti-TNF therapy: results of a case series
Ulf Martin Geisen1*, Mathias Voß2*,
Ruben Rose2*, Franziska Neumann3,
Carina Bäumler3, Sina Müller3, Lea
Paltzow3, Christina Martínez
Christophersen3, Merle Münier3,
Elena Hildebrand1, Paula Hoff4, Ann
Carolin Longardt5, Thomas Lorentz3,
Jan Henrik Schirmer1, Melike
Sümbül6, Florian Tran7,8, Dennis
Berner1, Helmut Fickenscher2, Sascha
Gerdes6, Stefan Schreiber7,8, Andi
Krumbholz2,3‡, Bimba Franziska
Hoyer1‡
1 Medical Department I, Rheumatology, and Clinical Immunology,
Christian-Albrecht University of Kiel and University Medical Center
Schleswig-Holstein Campus Kiel, Kiel, Germany
2 Institute for Infection Medicine, Christian-Albrecht University of
Kiel and University Medical Center Schleswig-Holstein, Campus Kiel,
Kiel, Germany
3 Labor Dr. Krause und Kollegen MVZ GmbH, Kiel, Germany
4 Department of Rheumatology, Endokrinologikum-Gruppe, Berlin, Germany
5 Department of Pediatrics, Christian-Albrecht University of Kiel and
University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany
6 Department for Dermatology, Christian-Albrecht University of Kiel and
University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany
7 Institute of Clinical Molecular Biology, Christian-Albrecht University
of Kiel, Kiel, Germany
8 Department for Internal Medicine I, Christian-Albrecht University of
Kiel and University Medical Center Schleswig-Holstein Campus Kiel
* ‡These authors contributed equally
Corresponding Author: Bimba Franziska Hoyer
Medical Department I, Rheumatology and Clinial Immunology,
University Medical Center Schleswig-Holstein
Arnold-Heller-Str. 3
24105 Kiel
Email:
bfhoyer@rheuma.uni-kiel.de
Phone: +49 431 500 22203